Table 1. Proline axis: regulatory effects on metabolic reprogramming and epigenetics .
Pathway | Enzyme | Regulation | Metabolic Effect | Clinical, Cellular Findings Epigenetic Mechanism |
---|---|---|---|---|
Degradative |
PRODH (POX) |
Upregulated by p53;35-37,42 Increased by AMPK43,44 under glucose deprivation and/or hypoxia |
ROS39–40 Increased α-KG;41 Decreased glycolysis Decreased Ox. Phos (Hancock, unpublished results) |
Apoptosis39-41 Blockade Cell Cycle41 Stem cell pluripotency68,69 Ins/IGF1 prosurvival signaling dependent on proline metabolism70,71 |
|
|
Decreased by miR-23b*45 and c-MYC46 |
|
permissive effect on cell proliferation46 |
|
|
Mutations in PRODH51 |
Hyperprolinemia51 |
Neuropsychiatric disorders |
Synthetic |
P5CS |
Induced by c-MYC46 |
Proline inreased Involved in c-MYC- stimulation of glycolysis (Warburg Effect) (Liu et al., unpublished results) |
necessary for c-MYC stimulated proliferation;46 essential for T-cell activation53 |
|
|
Inborn error59 |
Hypoprolinemia, Hypoornithinemia Hypoammonemia59 |
Neurodegeneration, mental deficiency, neuropathy connective tissue disorder59 |
|
PYCR1 |
Induced by c-MYC46 |
As for P5CS (Liu et al., unpublished results) |
As for P5CS (Liu et al., unpublished results) Knockdown in xenograft tumors inhibits tumor growth25 |
Inborn error56 | More sensitive to peroxide56 | Multiple genetic defects Cutis laxa, progeroid56 |